Departments of Epidemiology and Biostatistics, Brown University, 121 South Main Street, Providence, RI, 02912, USA.
Department of Epidemiology, Brown University, 121 South Main Street, Providence, RI, 02912, USA.
Eur J Epidemiol. 2016 Jun;31(6):625-33. doi: 10.1007/s10654-016-0118-x. Epub 2016 Jan 20.
Hepatitis B (HBV) and C (HCV) viruses cause many liver diseases. To move beyond statistical interaction, we aimed to assess the coordinated effect of the two viruses on mortality using mediation analyses. A prospective cohort study of 3837 residents in Taiwan examined participants seropositive for hepatitis B, of which 181 subjects (4.7 %) were co-infected by HCV and 589 died during follow-up. Mediation analyses for cause-specific mortality were performed using Cox proportional hazards model. Follow-up HBV viral load was inversely correlated with baseline HCV viral load (r(2) = -0.074; P < 0.001). For HCV serum viral load increasing from 800 to 404,000 IU/mL (minimum to median) at baseline, the effect of HCV mediated through HBV viral load decreased the all-cause mortality with a hazard ratio (HR) of 0.89 (95 % confidence interval (CI) 0.85, 0.94; P < 0.001), and the effect independent of HBV viral load had an opposite HR of 1.25 (95 % CI 0.98, 1.60; P = 0.08). The protective mediation effects of HCV viral load through HBV DNA level were observed in mortality from causes specific to liver-related diseases and liver cancer, but not in that from non-liver-related diseases. Our findings suggest a suppressive effect of HCV on mortality mediated through decreasing HBV viral load.
乙型肝炎(HBV)和丙型肝炎(HCV)病毒可引起多种肝脏疾病。为了超越统计学上的相互作用,我们旨在通过中介分析评估这两种病毒对死亡率的协同影响。一项对台湾 3837 名居民的前瞻性队列研究检查了乙型肝炎血清阳性的参与者,其中 181 名(4.7%)同时感染 HCV,589 名在随访期间死亡。使用 Cox 比例风险模型对特定原因死亡率进行中介分析。随访 HBV 病毒载量与基线 HCV 病毒载量呈负相关(r²=-0.074;P<0.001)。对于基线时 HCV 血清病毒载量从 800 增加到 404,000 IU/ml(最低到中位数),通过 HBV 病毒载量介导的 HCV 作用降低全因死亡率的风险比(HR)为 0.89(95%置信区间(CI)0.85,0.94;P<0.001),而独立于 HBV 病毒载量的作用具有相反的 HR 为 1.25(95%CI 0.98,1.60;P=0.08)。在与肝脏疾病和肝癌相关的死亡原因中观察到 HCV 病毒载量通过 HBV DNA 水平的保护中介作用,但在非肝脏疾病相关的死亡原因中未观察到。我们的研究结果表明,HCV 通过降低 HBV 病毒载量对死亡率具有抑制作用。